Neuroprotective agents for clinical trials in Parkinson’s disease: a systematic assessment.
E. Diguet, C. E. Gross, E. Bezard, F. Tison, N. Stefanova, G. K. Wenning, B. Ravina, S. Fagan, R. Hart, C. Hovinga, D. Murphy, T. Dawson, J. Marler
Neurology. 2004-01-12; 62(1): 158-159
DOI: 10.1212/wnl.62.1.158
Lire sur PubMed
Neurology. 2004-01-12; 62(1): 158-159
DOI: 10.1212/wnl.62.1.158
Lire sur PubMed